On November 9, 2009, Salix Pharmaceuticals, Ltd. issued a press release announcing its financial and operating results for the third quarter ended September 30, 2009. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein in its entirety by reference.

The information in this Item 2.02 (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

(d) Exhibits

Exhibit No.       Description

99.1              Press release dated November 9, 2009, regarding financial results
                  for the third quarter ended September 30, 2009.